Philippe Camus, M.D.

Dijon, France

Back

The Drug-Induced Respiratory Disease Website

Hydralazine

XII - Pericardial involvement

XII.b

Pericardial effusion (w/wo tamponade)
XII.e

Constrictive pericarditis - Pericardial thickening
XII.g

Pleural/pericardial effusion, ANA positive (DI lupus)
XII.n

Pleuropericarditis - Pleuropericardial effusion (ANA unknown or negative)

XV - Chest pain

XV.e

Pleuritis (can cause chest pain)

XVI - Hemorrhage - Bleeding - Hematoma(s)

XVI.e

Alveolar hemorrhage (AH), diffuse AH (DAH)
XVI.g

Alveolar hemorrhage, diffuse (ANCA-positive/-related)

XX - Vasculitis

XX.c

Vascultis (pulmonary, extrathoracic or systemic) - ANCA status unknown or negative
XX.d

Vasculitis, pulmonary (w/wo AH), extrathoracic, or systemic: ANCA-positive

XXII - Acute respiratory/cardiorespiratory failure

XXII.b

Acute lung injury - ARDS

XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.a

Pneumonitis (ILD)
XXIV.b

Pneumonitis (ILD), acute and/or severe (may cause ARDS)
XXIV.j

Organizing pneumonia (OP/BOOP) pattern (an area or areas of consolidation on imaging)

XXVIII - Large airway involvement

XXVIII.a

Angioedema (may cause UAO, asphyxia and death)
XXVIII.d

Vocal cord dysfunction, adduction, closure

XXIX - Small airway involvement

XXIX.a

Bronchospasm - Wheezing - Asthma
XXIX.b

Occupational asthma

XXXVI - Autoimmune syndromes - Systemic reactions or conditions

XXXVI.a

Autoimmunity - An autoimmune condition (+ANA, +anti-ds-DNA, +ANCAs, other auto-Abs)
XXXVI.b

Lupus - Lupus syndrome
XXXVI.m

DRES syndrome - DRESS-like reaction - Drug hypersensitivity syndrome
XXXVI.s

Dual MPO-/PR3-ANCA systemic disease/vasculitis or pseudovasculitis
XXXVI.t

Pneumorenal syndrome (w/wo ANCAs)
XXXVI.u

Pulmonary vasculitis or capillaritis

XXXVIII - Miscellaneous - Varia

XXXVIII.a

Upper airway obstruction other than angioedema or hematoma